News FDA rejects Mylan and Biocon biosimilar, citing manufacturin... Neulasta biosimilar hits trouble with regulators because of manufacturing issues
News Lilly's Verzenio fails in KRAS-mutated lung cancer Lilly's Verzenio has failed to show benefits in lung cancer patients with a KRAS mutation, denting the company's hopes of millions in extra revenues.
News Leukaemia patients to get access to AbbVie's Venclyxto via C... Cancer Drugs Fund will reimburse medicine on interim basis
News Immunocore hires Lilly's Hotchkiss as chief commercial offic... UK biotech leading in the nascent field of TCR immunotherapy has appointed Andrew Hotchkiss as its new Chief Commercial Officer.
News Endocyte bounces back with late-stage prostate cancer deal Endocyte saw its share price take off after acquiring rights to a promising late-stage cancer therapy.
News Moderna's Q1 revenues rocket, thanks to ex-US sales Moderna saw its Q1 sales nearly triple to $389m, almost a threefold rise on the same period of 2025, with international markets driving the increase.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
